Clinical trial
Ocrelizumab in Breastmilk
NCT04387110
Study timeline
Study start (actual)2020-08-07Date precision: day
Registry last updated2022-12-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Clinically Isolated Syndromeunresolved
Interventions
OcrelizumabDRUG
Sponsors & collaborators
University of California, San Franciscolead sponsor
Genentech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04387110 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.